Group 1 - The core point of the article highlights a significant drop in the stock price of Da Cheng Biochemical Technology, which fell by 10.0% to 0.099 yuan per share, with a trading volume of 3.9634 million yuan as of 15:30 on August 4 [1] - Da Cheng Biochemical Technology Group Limited is identified as a leading manufacturer of corn biochemical products in China, focusing on the production and sale of corn refining products [1] - The company is headquartered in Hong Kong, with its main production base located in the corn golden belt of Jilin Province [1] Group 2 - As of the 2024 annual report, Da Cheng Biochemical Technology reported total operating revenue of 1.853 billion yuan and a net profit of 713 million yuan [2]

Core Viewpoint - The company has successfully awarded an EPC contract for a boiler renovation project, which is essential for enhancing operational efficiency and competitiveness in the market [1][2] Group 1: Project Details - The EPC contract was signed on July 31, 2025, with a maximum cost of RMB 129.1 million, including potential early completion bonuses [1] - The boiler renovation project includes the construction of a new 150 tons/hour ultra-high temperature and ultra-high pressure circulating fluidized bed boiler, along with various supporting systems [1] - Additional components of the project involve the establishment of flue gas dust removal and denitrification systems, a new seawater desalination system, and upgrades to existing automation and control systems [1] Group 2: Strategic Importance - The renovation is necessary due to the outdated boiler facilities that have been in use for over 20 years, which limits the company's cost-effectiveness and sustainability [2] - The company primarily engages in the production and sale of corn refining products and biochemical products, and lacks the qualifications and capabilities for similar large-scale renovation projects [2] - By outsourcing the boiler renovation project to a qualified EPC contractor, the company aims to reduce administrative costs and select high-quality suppliers through competitive bidding [2]

诚如本公司截至2024年12月31日止年度的年报所披露，长春大合的生产设施于2024年全年保持正常营 运，并于年内为本集团贡献大量收入。尽管长春大合对本集团有重大财务贡献，惟自其生产厂区成立以 来超过20年间，长春大合一直使用中温/次高压锅炉及配套发电机组。鉴于中国广泛使用更具成本效益 的高温/高压及超高温/超高压锅炉，并考虑到本集团整体的可持续发展，长春大合有必要对其生产厂区 的锅炉设施进行翻修，并对锅炉机组进行系统升级，以降低成本并提升市场竞争力。由于本集团主要于 中国从事生产及销售玉米提炼产品及以玉米为原料的生化产品，本集团并无进行同类及类似规模翻修项 目的相关资质及能力。通过订立EPC合约，本集团可将锅炉翻修项目外判予合适的EPC承包商，从而减 少不必要的行政成本，并通过公平竞争选择优质供应商。 智通财经APP讯，大成生化科技(00809)发布公告，该公司已议决重新启动长春大合的锅炉翻修项目，并 拟通过与合适的EPC 承包商签订EPC合约，以(其中包括)对长春大合的锅炉设施进行翻修。由于本公司 的控股股东最终由吉林省国资委控制，本集团须通过公开招标方式为锅炉翻修项目遴选合适的EPC承包 商，且本公司须 ...